Maternal mosaicism is a significant contributor to discordant sex chromosomal aneuploidies associated with noninvasive prenatal testing.
about
Non-invasive prenatal testing for fetal chromosome abnormalities: review of clinical and ethical issuesNon-Invasive Prenatal Testing Using Cell Free DNA in Maternal Plasma: Recent Developments and Future ProspectsToo much, too soon?: Commercial provision of noninvasive prenatal screening for subchromosomal abnormalities and beyondCopy-number variation and false positive prenatal aneuploidy screening results.Clinical Utility of Non-Invasive Prenatal Screening from Maternal Blood.Evaluation of preferences of women and healthcare professionals in Singapore for implementation of noninvasive prenatal testing for Down syndrome.Six consecutive false positive cases from cell-free fetal DNA testing in a single referring centreThe feasibility study of non-invasive fetal trisomy 18 and 21 detection with semiconductor sequencing platform.Non-invasive prenatal testing for sex chromosome abnormalities: a source of confusionAnalysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis.Comparison of two high-throughput semiconductor chip sequencing platforms in noninvasive prenatal testing for Down syndrome in early pregnancyAbnormal plasma DNA profiles in early ovarian cancer using a non-invasive prenatal testing platform: implications for cancer screening.An adaptive detection method for fetal chromosomal aneuploidy using cell-free DNA from 447 Korean women.Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening.Statistical Approach to Decreasing the Error Rate of Noninvasive Prenatal Aneuploid Detection caused by Maternal Copy Number VariationCell free fetal DNA testing in maternal blood of Romanian pregnant womenMolecular characterization of a novel ring 6 chromosome using next generation sequencing.Clinical application of next-generation sequencing in preimplantation genetic diagnosis cycles for Robertsonian and reciprocal translocations.Enlarged NT (≥3.5 mm) in the first trimester - not all chromosome aberrations can be detected by NIPT.Clinical evaluation of the IONA test: a non-invasive prenatal screening test for trisomies 21, 18 and 13.Implementation of whole genome massively parallel sequencing for noninvasive prenatal testing in laboratories.Clinical implementation of NIPT - technical and biological challenges.Noninvasive Prenatal Screening for Genetic Diseases Using Massively Parallel Sequencing of Maternal Plasma DNARare autosomal trisomies, revealed by maternal plasma DNA sequencing, suggest increased risk of feto-placental disease.Cytogenetic confirmation of a positive NIPT result: evidence-based choice between chorionic villus sampling and amniocentesis depending on chromosome aberration.Survey of US obstetrician opinions regarding NIPT use in general practice: implementation and barriers.Advances in the Interdisciplinary Care of Children with Klinefelter Syndrome.Cell-Free DNA Screening: Complexities and Challenges of Clinical Implementation.Characterization of chromosomal abnormalities in pregnancy losses reveals critical genes and loci for human early development.Prenatal and pre-implantation genetic diagnosis.Noninvasive prenatal testing for aneuploidy using cell-free DNA - New implications for maternal health.Clinical, social and ethical issues associated with non-invasive prenatal testing for aneuploidy.Validation of a method for noninvasive prenatal testing for fetal aneuploidies risk and considerations for its introduction in the Public Health System.Recommended practice for laboratory reporting of non-invasive prenatal testing of trisomies 13, 18 and 21: a consensus opinion.Traditional karyotyping vs copy number variation sequencing for detection of chromosomal abnormalities associated with spontaneous miscarriage.Position statement from the Chromosome Abnormality Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis.Cell-free fetal DNA: the new tool in fetal medicineClinical implementation of cell-free DNA-based aneuploidy screening: perspectives from a national audit.Diagnostic cytogenetic testing following positive noninvasive prenatal screening results: a clinical laboratory practice resource of the American College of Medical Genetics and Genomics (ACMG).In silico size selection is effective in reducing false positive NIPS cases of monosomy X that are due to maternal mosaic monosomy X.
P2860
Q26764809-B3220FC6-E111-42FE-A1C3-00D4EEEEF6F7Q26827338-6BAFF8D2-BEE3-4238-892E-D72AEF2371FEQ26998800-F0DDD82A-CEB8-46FF-8B07-FD713F5C6FFDQ30643919-2FAE0A7D-4CD5-4890-926A-F88F17F70EE8Q33572406-35BA8D90-E266-42B7-9BDE-6A5B7B0CCDE3Q33809800-52041B74-FDB9-4191-A33D-9FDA438E6B3FQ34295095-BC6711CA-D17E-4B0F-AB6F-168B0F90D37FQ34374066-4CEF7FB8-BAEB-48A4-BAD1-A216E8AF2B15Q35065456-AF776D6C-02FD-40F3-8C95-F324E3838EEEQ35552815-D4EF4FB4-289D-48CA-946B-BA3910A0BC57Q36003623-D89317DA-04FD-4EE8-960F-FD761FFAE20BQ36112242-B2333377-A66A-4705-B292-58BF54E182DDQ36157384-2306A3AB-618F-4713-95BE-806760FD2B98Q36184534-DBCFAC03-E70E-4083-9923-195D7DCB925BQ36245906-0B271E0B-F1BA-4573-A880-03A649E309CCQ36343256-9EDF79D9-8E35-4991-B491-D2FA23872A13Q36820481-3491D194-B6B6-4763-968E-AFD7112733DCQ37059987-E4243575-D747-444F-992C-02E2F4B46D46Q37240193-607A23D9-EAEC-4B97-A9F9-0832D636E2DCQ37340255-2EF0C82B-0A37-4A03-AD18-A350D2B86172Q38262952-DB845A63-A1CA-4838-94A5-DAD8087EDC47Q38418240-643A91AC-0406-468A-8828-04EA4BDD99C8Q38549770-E962D4E9-1C2D-4022-98B3-16185DCF24B8Q38601652-EEE68ECD-F471-41B1-B368-599E8B5137BDQ38728695-81CA7CF7-7B53-4CD9-8752-CCC06EA9B91BQ38824972-6A251820-2974-4BF5-9D4D-F7F6FDABF4F4Q38900036-FC2281EA-73FC-454C-9807-481FB015BA35Q38928166-684ABB0A-06EF-4944-9EEB-FBD201C324C9Q38936232-DF5693D5-DE71-42F1-BED1-8C23ED798B9EQ38954748-80C2DD65-99B6-4E31-8BC6-673F2F69F06FQ39004076-9797BF20-256C-466A-8C00-64CFE66B4B42Q39387768-536C828E-1F14-45DA-A511-06DC69F9BF2BQ39735567-0A3F6590-88D6-433B-90F8-CBA4E4456520Q41113357-E7CE703A-E79C-4DDC-B1B6-D88A29F0649CQ41231906-E58451AA-218F-4E02-9967-C386D051727CQ41235376-79379529-43DD-438F-A4D8-5F085A6C5E82Q42393162-8B5DBC16-AFE2-40C2-A71F-6A1969FD35F8Q44733231-5866076B-5126-4A73-92F7-87AA72F54E82Q46058669-68F985F0-8DDF-4407-9451-77AC12776C22Q47177655-FEEFCA08-69F6-4A84-8F85-E93366A1A90D
P2860
Maternal mosaicism is a significant contributor to discordant sex chromosomal aneuploidies associated with noninvasive prenatal testing.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Maternal mosaicism is a signif ...... noninvasive prenatal testing.
@ast
Maternal mosaicism is a signif ...... noninvasive prenatal testing.
@en
type
label
Maternal mosaicism is a signif ...... noninvasive prenatal testing.
@ast
Maternal mosaicism is a signif ...... noninvasive prenatal testing.
@en
prefLabel
Maternal mosaicism is a signif ...... noninvasive prenatal testing.
@ast
Maternal mosaicism is a signif ...... noninvasive prenatal testing.
@en
P2093
P1433
P1476
Maternal mosaicism is a signif ...... noninvasive prenatal testing.
@en
P2093
David Cram
Jianguang Zhang
Weiwei Cheng
Wenjing Hu
Yanlin Wang
P304
P356
10.1373/CLINCHEM.2013.215145
P407
P577
2013-11-05T00:00:00Z